Baxter 2021 Corporate Responsibility Report 8 Corporate Responsibility Commitment 2030 Corporate Responsibility Goals Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Introduction Cross-Cutting Commitments Corporate Responsibility Commitment Baxter is committed to addressing the environmental, social and governance (ESG) issues touching our patients, employees and the diverse communities we serve worldwide. Our corporate responsibility work is grounded in three pillars and bolstered by our approach to good governance and cross-cutting commitments to responsible practices across our business. Our 2030 Corporate Responsibility Commitment features 10 goals for prioritized action. We have reported our environmental performance for 30 years and have consistently broadened and enhanced our reporting on the ESG issues that are priorities to Baxter and our stakeholders. Baxter published its first Sustainability Accounting Standards Board (SASB) Index in 2020 (based on 2019 information), in alignment with the Medical Equipment and Supplies Sustainability Accounting Standard. In addition, in early 2022, we commissioned a third party to conduct a gap analysis comparing the information in our 2020 Corporate Responsibility Report and our 2021 CDP Climate Change disclosure with the Task Force on Climate-related Financial Disclosures (TCFD) framework. We are actively evaluating our ability to report against the TCFD framework generally and in light of potential evolving regulatory disclosure requirements. Performance Goals Every year, we measure and evaluate our performance, communicate progress and challenges, and identify opportunities to drive even greater impact across our business and society. Setting goals across a broad range of ESG issues demonstrates our commitment, reinforces accountability and helps to drive ongoing improvement. This report states progress toward Baxter’s 2030 Corporate Responsibility Goals. We developed our 2030 goals through broad engagement with Baxter executives, our Board of Directors (Board) , subject matter experts across the company, investors, nongovernmental organizations and other external stakeholders. Industry and cross-industry benchmarking, as well as our most recent materiality assessment, also informed the process. Given the scale and scope of the challenges we face as a society, we chose a 10-year timeframe for most of our goals to advance meaningful progress related to these substantive issues. CORPORATE RESPONSIBILITY PILLARS Empower Our Patients Protect Our Planet Champion Our People and Communities CROSS-CUTTING COMMITMENTS Ethics and Compliance Human Rights Diversity, Equity and Inclusion Privacy and Data Protection